Rapport Therapeutics

Rapport Therapeutics is a clinical-stage biopharmaceutical company developing precision neuroscience medicines for people with central nervous system (CNS) disorders. Its platform targets receptor associated proteins (RAPs) to create small-molecule therapies that act on specific brain regions and circuits. Lead programs include RAP-219 for focal epilepsy and other neurological conditions, such as bipolar mania and neuropathic pain.